AstraZeneca rejects new Pfizer bid

UK drugs company AstraZeneca has rejected an improved "final" takeover offer from US drugs giant Pfizer.

Pfizer had made a new offer of £55 per share, valuing AstraZeneca at about £69bn.

The BBC's Steph McGovern reports.